- October 13, 2021
In the latest issue of the Quatrefolic 360° collection, discover how the level of folate available can be linked to infertility and how Quatrefolic®, the active form of folate, is the right solution to support conception projects.
Globally, not less than 48 million to 186 million individuals have a fertility issue. Recently, studies have highlighted the importance of folate level and homocysteine status as critical factors in the early stages of human reproduction.
How folate is correlated to fertility?
Women and men experiencing fertility issues can present low folate availability, often linked to the MTHFR enzyme polymorphism.
Preconceptionally folate supplementation seems to have positive reproductive outcomes in natural pregnancies and pregnancies after assisted reproductive technology (ART) treatment.
In women, inadequate folate levels increase homocysteine levels in the blood. and oxidative stress, one of the factors related to the pathogenesis of fertility disorders such as idiopathic infertility, polycystic ovarian syndrome, and endometriosis.
In men, folate is essential for spermatogenesis. Low folate levels in semen can be associated with poor sperm stability and DNA damage.
Quatrefolic® the right choice of folate
Thanks to its bioavailability that bypasses the MTHR polymorphism, Quatrefolic® provides the adequate folate dosage. It does not require the metabolism of the MTHFR enzyme and is ready to enter human metabolism to normalize homocysteine plasma levels.
DISCOVER ALL OUR LATEST NEWS
Webinar: The stable probiotic for immunity in a new intestine-on-chip model
Register to the upcoming webinar: LifeinU™ BSCU1 in a new scientific model: intestine-on-chip on December 14, 2021 – 11:00 AM EDT
WEBINAR: The benefits of Quatrefolic®, the innovactive folate
Folate is one of the most common vitamin deficiencies, also because body requires the conversion of folic acid to its active form, methylfolate.
Unlocking the research on probiotics and immunity
To innovate in a better and more sustainable way, Gnosis by Lesaffre has developed, with a partner, a new dynamic model that mimics the human model in preclinical stages called the gut-on-chip model.
